Cargando…

Stepwise mass screening for atrial fibrillation using N-terminal B-type natriuretic peptide: the STROKESTOP II study

AIMS: To study the prevalence of unknown atrial fibrillation (AF) in a high-risk, 75/76-year-old, population using N-terminal B-type natriuretic peptide (NT-proBNP) and handheld electrocardiogram (ECG) recordings in a stepwise screening procedure. METHODS AND RESULTS: The STROKESTOP II study is a po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kemp Gudmundsdottir, Katrin, Fredriksson, Tove, Svennberg, Emma, Al-Khalili, Faris, Friberg, Leif, Frykman, Viveka, Hijazi, Ziad, Rosenqvist, Mårten, Engdahl, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945054/ https://www.ncbi.nlm.nih.gov/pubmed/31790147 http://dx.doi.org/10.1093/europace/euz255

Ejemplares similares

Cost-effectiveness of population screening for atrial fibrillation: the STROKESTOP study
por: Lyth, Johan, et al.
Publicado: (2022)

Clinical and echocardiographic characteristics of individuals aged 75/76 years old with screening-detected elevated NT-proBNP levels
por: Al-Khalili, Faris, et al.
Publicado: (2020)

Decentralising atrial fibrillation screening to overcome socio-demographic inequalities in uptake in STROKESTOP II
por: Gudmundsdottir, Katrin Kemp, et al.
Publicado: (2020)

Brief episodes of rapid irregular atrial activity (micro-AF) are a risk marker for atrial fibrillation: a prospective cohort study
por: Fredriksson, Tove, et al.
Publicado: (2020)

Intermittent vs continuous electrocardiogram event recording for detection of atrial fibrillation—Compliance and ease of use in an ambulatory elderly population
por: Fredriksson, Tove, et al.
Publicado: (2020)

Performance of pulse palpation compared to one‐lead ECG in atrial fibrillation screening
por: Gudmundsdottir, Katrin Kemp, et al.
Publicado: (2021)

Adherence to a mobile health-based atrial fibrillation screening program: a subanalysis from STROKESTOP I and II
por: Van Der Velden, R, et al.
Publicado: (2023)

The association between adherence to a systematic atrial fibrillation screening program and clinical outcomes: a subanalysis from the STROKESTOP study
por: Van Der Velden, R, et al.
Publicado: (2023)

Prognostic implication of premature ventricular contractions in patients without structural heart disease
por: Scorza, Raffaele, et al.
Publicado: (2022)

Screening for atrial fibrillation: all invitees are equal, but some are more equal than others?
por: Engdahl, Johan, et al.
Publicado: (2023)

Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care
por: Ghazal, Faris, et al.
Publicado: (2019)

Evaluation of patients with high burden of premature ventricular contractions by comprehensive transthoracic echocardiography
por: Scorza, Raffaele, et al.
Publicado: (2022)

Magnetic Resonance Detects Structural Heart Disease in Patients with Frequent Ventricular Ectopy and Normal Echocardiographic Findings
por: Scorza, Raffaele, et al.
Publicado: (2021)

Prognostic impact of morphology and duration of premature ventricular contractions in a population without structural heart disease
por: Scorza, Raffaele, et al.
Publicado: (2023)

Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation
por: Friberg, Leif, et al.
Publicado: (2019)

Feasibility and outcomes of atrial fibrillation screening using intermittent electrocardiography in a primary healthcare setting: A cross-sectional study
por: Ghazal, Faris, et al.
Publicado: (2018)

Validity of daily self-pulse palpation for atrial fibrillation screening in patients 65 years and older: A cross-sectional study
por: Ghazal, Faris, et al.
Publicado: (2020)

An artificial intelligence–based model for prediction of atrial fibrillation from single-lead sinus rhythm electrocardiograms facilitating screening
por: Hygrell, Tove, et al.
Publicado: (2023)

Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
por: Friberg, Leif, et al.
Publicado: (2012)

Uptake of atrial fibrillation screening aiming at stroke prevention: geo-mapping of target population and non-participation
por: Engdahl, Johan, et al.
Publicado: (2013)

Risk of ischemic stroke and utility of CHA(2)DS(2)‐VASc score in women and men with atrial fibrillation
por: Tomasdottir, Maria, et al.
Publicado: (2019)

Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
por: Atterman, Adriano, et al.
Publicado: (2021)

Large‐scale screening studies for atrial fibrillation – is it worth the effort?
por: Engdahl, J., et al.
Publicado: (2021)

Examining the continuum of resistance model in two population-based screening studies in Sweden
por: Nilsson, Anton, et al.
Publicado: (2023)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Out of hospital cardiac arrest outside home in Sweden, change in characteristics, outcome and availability for public access defibrillation
por: Ringh, Mattias, et al.
Publicado: (2009)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

N‐Terminal Pro Brain, N‐Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation
por: Mahinrad, Simin, et al.
Publicado: (2020)

Atrial fibrillation among patients under investigation for suspected obstructive sleep apnea
por: Hendrikx, Tijn, et al.
Publicado: (2017)

Drotrecogin alfa (activated) reduces the plasma levels of N-terminal prohormone atrial natriuretic peptide and N-terminal prohormone brain natriuretic peptide as markers of cardiac depression in septic patients
por: Hoffmann, U, et al.
Publicado: (2004)

NK Cell Terminal Differentiation: Correlated Stepwise Decrease of NKG2A and Acquisition of KIRs
por: Béziat, Vivien, et al.
Publicado: (2010)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Marked elevations in N-terminal brain natriuretic peptide levels in septic shock
por: Chua, Gerald, et al.
Publicado: (2004)

The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology
por: Kimmenade, Van, et al.
Publicado: (2007)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_o3t7qhe4o66o4hv7fc79poajf6